|
Volumn 34, Issue 7, 2002, Pages 2916-2919
|
Bolus anti-thymocyte globulin induction in renal transplant recipients: A comparison with conventional ATG or anti-interleukin-2 receptor antibody induction
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
BASILIXIMAB;
COTRIMOXAZOLE;
CYCLOSPORIN;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE ACETATE;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NYSTATIN;
OKT 3;
POLYCLONAL ANTIBODY;
PREDNISONE;
SODIUM CHLORIDE;
THYMOCYTE ANTIBODY;
CREATININE;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
ADULT;
ALLOGRAFT;
CANCER RISK;
CELL ACTIVATION;
CHI SQUARE DISTRIBUTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTRACEPTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOTOXICITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG RESISTANCE;
DRUG TOLERABILITY;
ECHOGRAPHY;
FEMALE;
FISHER EXACT TEST;
GRAFT SURVIVAL;
HELPER CELL;
HEPATITIS B VIRUS;
HLA MATCHING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HYPERLIPIDEMIA;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
INTERMETHOD COMPARISON;
KIDNEY BIOPSY;
KIDNEY DONOR;
KIDNEY FAILURE;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY SCINTISCANNING;
LABORATORY TEST;
LEUKOPENIA;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NEPHROTOXICITY;
PHYSICAL EXAMINATION;
PREGNANCY;
PRIORITY JOURNAL;
PROTEIN INDUCTION;
REVASCULARIZATION;
SERODIAGNOSIS;
SIDE EFFECT;
SIMULATION;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ACUTE DISEASE;
ADOLESCENT;
ARTICLE;
BLOOD;
CLASSIFICATION;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
GRAFT REJECTION;
IMMUNOLOGY;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTILYMPHOCYTE SERUM;
CREATININE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRAVENOUS;
KIDNEY TRANSPLANTATION;
MALE;
METHYLPREDNISOLONE;
POSTOPERATIVE COMPLICATIONS;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
TREATMENT OUTCOME;
|
EID: 0036844638
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03487-5 Document Type: Conference Paper |
Times cited : (13)
|
References (36)
|